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ABSTRACT: The use of polymers has revolutionized the field of drug delivery in the past two decades. Properties such as poly-
mer size, charge, hydrophilicity or branching have all been shown to play an important role on the cellular internalization of poly-
meric systems. In contrast, the fundamental impact of monomers distribution on the resulting biological properties of copolymers 
remains poorly studied, and is always only investigated for biologically-active self-assembling polymeric systems. Here, we ex-
plore the fundamental influence of monomer distribution on the cellular uptake of non-aggregating and biologically passive copol-
ymers. Reversible addition−fragmentation chain-transfer (RAFT) polymerization was used to prepare precisely-defined copolymers 
of three hydrophilic acrylamide monomers. The cellular internalization of block copolymers was compared with the uptake of a 
random copolymer where monomers are statistically distributed along the chain. The results demonstrate that monomer distribution 
in itself has a negligible impact on copolymer uptake. 
Over the past few decades, the use of polymers in biomedi-
cine, either in the form of soluble polymers or nanostructures, 
has revolutionized the field of drug delivery. Pharmacological 
advantages of using polymer carriers include enhanced solu-
bility, protection against harsh physiological conditions, ex-
tension of in-vivo lifetime or accumulation in cancer tissues 
due to EPR effect.1-3 Polymers are also known to facilitate the 
transfer of cargos across biological barriers and have been 
widely used as cell uptake enhancers.4 The chemical and phys-
ical properties of polymeric systems are known to play an 
important role on their cellular internalization and factors such 
as polymer size,5-6 charge,7 hydrophilicity,8-9 self-assembling 
behavior,10 degree of cross-linking,11 or branching12 have al-
ready been shown to affect cell uptake.  
Less studied is the impact of monomer distribution on the 
biological properties of copolymers. A few reports demon-
strated that monomer distribution can have a significant im-
pact on the ability of polymers to condense DNA or siRNA 
and carry them inside cells.13 Copolymers of carbohydrate and 
cationic monomers have received particular attention as nucle-
ic acid carriers, yet conclusion on the monomer distribution 
influence seems to differ from one system to another.14-16 
Nonviral gene delivery is a complicated process that combines 
nucleic acid complexation, cell uptake, cargo release and nu-
cleus membrane crossing. This makes understanding the role 
of monomer distribution very challenging, and highlights the 
need for a more fundamental approach to studying the influ-
ence of polymer architecture on cell uptake.  
The use of modern polymerization techniques such as re-
versible addition−fragmentation chain transfer (RAFT) 
polymerization or atom-transfer radical-polymerization 
(ATRP) has rendered ready accessibility to the preparation of 
precisely-defined copolymers.17-18 Copolymers can be ar-
ranged in blocks where a particular sequence of (co)monomers 
can be dictated along the same polymeric chain, or as ‘ran-
dom’ copolymers where monomers are statistically distributed 
along the chain.19-20 This allows for an easier tuning of poly-
mer physical properties and a better control over the introduc-
tion of various functionalities. By mixing together monomers 
with different hydrophobicity, copolymers are also ideal tools 
to create nanostructures such as micelles or vesicles.21-22 Pre-
viously, Barz et al. reported that statistical copolymers of hy-
drophobic and hydrophilic methacrylamide monomers inter-
nalized better than their block copolymer counterparts due to 
differences in aggregation behavior.23 In contrast, the cellular 
uptake of block copolymers from oxazoline derivatives of 
various hydrophobicity was shown, using covalently-bound 
horseradish peroxidase, to be superior to the uptake of their 
statistical equivalent. These results were associated with the 
absence of amphiphilicity of the random polymer.24 Reduction 
of haemolytic activity was also demonstrated for antibacterial 
polymers made out of amphiphilic blocks as compared to the 
randomized version of the same copolymer. Again, differences 
in monomer hydrophobicity leading to different folding of the 
Table 1. Characteristics of copolymers prepared in this study 
polymers was identified as the main reason for the dissimilari-
ty in cellular behavior.25 In all, it is becoming clear that cellu-
lar internalization is indeed influenced by monomer selection, 
in different ways for each polymeric system considered, mak-
ing it difficult to draw general conclusions. This is further 
complicated by the fact that studies to date focused exclusive-
ly on the uptake of amphiphilic copolymers that tend to self-
assemble or fold in aqueous solution.26-28 While these results 
are pertinent for drug delivery systems that rely on micelles or 
vesicle formation, an understanding of the fundamental influ-
ence of monomer composition on the uptake of single chain 
copolymers is clearly lacking. In an attempt to fill this 
knowledge gap, we explored the cellular uptake of various 
copolymers that do not self-assemble in solution. Various co-
polymers were prepared using RAFT polymerization, func-
tionalized with a dye and the cellular internalization of block 
versus randomized copolymers compared.  
Acrylamide monomers were chosen for this study as they 
are robust, stable towards hydrolysis, and provide high reactiv-
ity ratio which makes possible the preparation of well-defined 
block and random copolymers. (N-acryloylmorpholine 
(NAM), (N-(2-hydroxyethyl)acrylamide) (HEAm) and (N,N-
dimethylacrylamide) (DMA) were selected as representative 
acrylamide monomers. They are neutral monomers that do not 
induce a lower critical solution temperature (LCST) and, to the 
best of our knowledge, do not show specific interactions with 
biological targets that could interfere with our study. They are 
have been widely used for biomedical applications and were 
previously shown to be non-toxic to cells.29-34 While strictly 
hydrophobic monomers were avoided here to prevent aggrega-
tion, this trio of monomers covers an interesting gradient of 
hydrophilicity (HEAm > NAM >DMA) which is expected to 
affect the interaction of the resulting copolymers with both 
extracellular proteins and the lipid bilayer of cells.35-36 A com-
bination of triblock copolymers (A, B and C), consisting each 
of 20 units of these three monomers in various sequences, was 
considered as the most efficient way to study this system 
(Scheme 1). Additionally, a statistical polymer (p(DMA)-r-
p(HEAm)-r-p(NAM)) (R) was also studied as an isomeric 
analogue to the block copolymers without the sequence de-
fined blocks of monomers. The block copolymers were syn-
thesized via sequential RAFT polymerization, using a recent-
ly-described technique that has been demonstrated, both theo-
retically and experimentally, to yield high end-group 
fidelity.37-38 Statistical copolymer R was prepared using a one-
pot RAFT polymerization of the three monomers. Table 1 
summarizes structures and characteristics of the polymers used 
in the study. Measurement of the polymerization conversion 
using 1H-NMR shows that all four copolymers are of compa-
rable Mn,th values. The fact that the molecular weight reported 
for copolymer R is lower than that of A, B and C is a known 
artifact of DMF-SEC analysis, and is due to differences in 
hydrodynamic volume between pHEA and poly(methyl meth-
acrylate) standards used for calibration.39-40 In the case of A, B 
and C, grouping of HEAm monomers into blocks enhances 
this effect, resulting in molecular weight values that appear 
higher than for random copolymer R. In reality, we expect the 
size for all four copolymers to be comparable, and relatively 
close to Mn,th. 
Functionalization of the block copolymers with a fluores-
cent moiety was obtained in a one pot reaction, by reducing 
the trithioester group of the chain-transfer agent (CTA) into a 
thiol and reacting it with maleimide-functionalized fluorescein 
(Scheme 1). Special care was taken in optimizing this step to 
ensure that subsequent experiments are conducted with uni-
formly-functionalized polymers. The approach used here is 
based on previous reports and should ensure maximal func-
tionalization of each polymer chains.41-43 The reaction was 
Scheme 1. Fluorescently-labelled block and random copoly-
mers
Figure 1. a) Fluorescence profile of the block copolymers and 
random copolymer. Fluorescence values at 50 µg.mL-1 (see in-
sert) were used to calculate the fluorescence correction factor; b) 
cellular toxicity of copolymers against HeLa cells after 24 hours 
incubation in the presence of various concentrations of copoly-
mers as measured using MTT assay.
 allowed to run for six days to drive it towards completion, 
following which three purification steps (precipitation, filtra-
tion and size-exclusion chromatography) were undertaken to 
ensure complete removal of unconjugated dye molecules. 
Functionalized polymer chains were characterized via dynam-
ic light scattering (DLS) to confirm the absence of larger self- 
assembled structures. Measurements in PBS show a hydrody-
namic diameter comprised between 4.5 and 7.5 nm for both 
CTA-polymers and fluorescein-polymers (Figure S1). Due to 
the hydrophilic nature of these polymers, they are expected to 
behave as well-solvated single-chains in aqueous solvents. 
According to the literature, the mean-square end-to-end dis-
tance of polyacrylamide chains (7500 Da) in water is approx-
imately 3.2 nm.44 Using the Stokes-Einstein equation and dif-
fusion coefficients reported by Chamignon et al., the hydrody-
namic radius for a linear pNAM of similar molecular weight in 
PBS (pH = 7.4) can be estimated around 2 nm.45 Considering 
these data, the particle hydrodynamic diameters measured by 
DLS appear to match, or slightly exceed, the values expected 
for single molecules. Difficulties in measuring light scattering 
in the presence of large interfering macromolecules prevent us 
for characterizing the polymers behavior in culture media. As 
a consequence, it is not possible to definitely conclude on 
whether polymers are present as single molecules in cell cul-
ture media. Yet, for the cell culture experiments described 
hereafter, we assumed that these hydrophilic polymers are 
present as single molecules, or at worst aggregates of very few 
molecules.  
Fluorescence spectroscopy measurement of the resulting 
polymers shows spectra comparable to that of free fluorescein 
with small differences due to covalent attachment to the poly-
mer (Figure 1, a), but also a trend in fluorescence intensity for 
the different copolymers (R > B > C > A). To determine 
whether this is due to the presence of free dye molecules or 
simply to minor differences in RAFT end-group fidelity of the 
initial polymers, the UV-Vis spectra of the polymers was 
measured prior to their functionalization. The data, presented 
in Figure S2, shows a clear correlation between the UV-
absorption of the CTA-bearing polymers at 310 nm and fluo-
rescence of the fluorescein-bearing polymers at 490 nm, indi-
cating that differences in the intrinsic fluorescence of the func-
tionalized polymers are likely due to the absence of trithiocar-
bonate end-groups on dead chains, to different extents depend-
ing on the polymer. Indirectly, this result confirms that no free 
dye molecules remains in our system. To account for these 
differences, a fluorescence correction factor was calculated 
using the fluorescence spectra of each polymer and was used 
to compensate for intrinsic fluorescence discrepancy (Table 
S1). The validity of this correction was assessed by comparing 
results obtained when cells were exposed to solutions contain-
ing copolymers with equivalent fluorescence intensities 
against results obtained when cells were incubated with equiv-
alent concentrations of polymers and corrected with the fluo-
rescence correction factor instead (Figure S3).  
Next, we turned to characterizing the cellular uptake of the-
se copolymers. In similar studies, Barz and coworkers23 used 
concentrations in the range of 0.2 to 1000 µg/mL while 
Garofalo et al.26 did not exceed 92.5 µg/mL. Preliminary stud-
ies with copolymer R in HeLa cells (2 hours incubation time) 
showed that a concentration 50 µg/mL struck a balance of 
being sufficiently fluorescent while having a fluorescence low 
enough to avoid saturation-induced screening of potential dif-
ferences in uptake efficiencies (data not shown). Cytotoxicity 
assays confirmed that all four copolymers are non-toxic at this 
concentration (Figure 1,b). The cell uptake of each copolymers 
in ovarian cancer A2780 and cervical cancer cells HeLa is 
reported in Figure 2. For each experiment, the fluorescence 
intensity of 30,000 live cells from each replicate (n = 6) was 
measured, the median of these data points averaged and cor-
rected with the fluorescence factor to give the values reported 
for each polymer (Table S1). Incubation of A2780 cells with 
solutions of copolymers A, B, C and R for 2 hours, followed 
by throughout washes to remove non-internalized polymers, 
showed a positive uptake of each of the polymer. Block co-
polymers A, B and C showed negligible uptake differences 
between each other’s, whereas statistical polymer R showed a 
significantly higher uptake (p < 0.002). A similar trend was 
observed for HeLa cells incubated with copolymers for the 
same amount of time, although the difference between R and 
A-C was less significant (p < 0.1 for R and A, and p < 0.01 for 
R and B-C). These experiment indicates that monomer distri-
bution has a minor influence on copolymer cell uptake after 2 
hours, with statistical distribution of the monomer showing an 
increase in uptake as compared to block counterparts estimat-
ed to 36 % and 18 % for A2780 and HeLa cells, respectively.  
In order to gauge whether these results are time-dependent 
or represent a state of equilibrium, uptake of the polymers by 
HeLa cells was measured after 24 hours incubation time. The 
results show an increase of the intracellular fluorescence for 
block copolymers A, B and C (by 28 %, 32 % and 18 %, re-
spectively) compared to the samples incubated for 2 hours 
(Figure 2,c). In contrast, the amount of fluorescently-labelled 
R in the cells remained the same than after 2 hours of incuba-
tion. As a result, the intracellular fluorescence after overnight 
incubation showed no significant differences in intensity be-
tween each of the block copolymers, and showed no signifi-
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Figure 2. Fluorescence intensity measured in a) A2780 cells incubated for 2 h, b) HeLa cells incubated for 2 h, c) HeLa cells incubated for 
24 h at 37 °C, in the presence of block copolymers or random copolymer (50 µg/mL or equivalent). Data represent the mean of fluores-
cence ± SD for two independent experiments done in triplicates. (*) p < 0.1, (**) p < 0.01, (***) p < 0.001. 
 cant intensity differences between block polymers and the 
statistical polymer. Taken together, these data show that mon-
omer distribution does not have an influence on the uptake of 
copolymers by cells in the long term, but that the internaliza-
tion of copolymer R reaches their maximum intracellular con-
centration slightly faster than its block counterparts (A, B and 
C).  
The copolymers being neutral and similar in size and aggre-
gation behavior, we hypothesize that changes in cell uptake 
behavior are possibly related to slight differences in the copol-
ymers hydrophilicities. The consensus in drug delivery is that 
increased hydrophobicity of macromolecules or nanostructures 
results in enhanced interaction with the cell membrane and 
generally facilitate cell uptake.35, 46 Here, we argue that statis-
tical distribution of the monomers in our system results in a 
copolymer R that is slightly more hydrophobic than its block 
counterparts. An alternative explanation is that the random 
arrangement of monomers in R results in a greater diversity of 
consecutive monomer patterns, leading to increased non-
specific interactions as compared to the block copolymers (A, 
B and C). Biologically-inert macromolecules are expected to 
enter the cells via non-selective endocytosis pathways such as 
pynocytosis.47 Both modifying the hydrophilicity of the stud-
ied copolymers and increasing their ability to form non-
specific interactions with molecules on the cell surface are 
expected to modify the endocytosis rate of polymers and ac-
count for the slightly faster internalization of R versus A-C. 
Yet, we have demonstrated that these differences become neg-
ligible as the incubation proceed for amounts of time superior 
to two hours. 
In conclusion, we have studied the fundamental influence of 
monomer distribution on the cellular uptake of non-
aggregating copolymer chains and demonstrated that monomer 
distribution in itself, that is for polymeric systems that are 
biologically passive, has a minor to negligible impact on co-
polymer uptake overall. Although the random distribution of 
monomers seemed to favor internalization at first, we showed 
that it has no significant impact in the longer term. 
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